Gan & Lee Pharmaceuticals. (SHA:603087)
China
· Delayed Price · Currency is CNY 46.09
-0.31 (-0.67%)
Apr 3, 2025, 2:45 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 27.70 billion as of April 2, 2025. Its market cap has increased by 11.32% in one year.
Market Cap
27.70B
Enterprise Value
22.64B
Revenue
2.95B
Ranking
n/a
PE Ratio
47.06
Stock Price
46.09
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has decreased from 36.57B to 27.70B, a decrease of -24.25%. That is a compound annual growth rate of -5.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2025 | 27.70B | 5.22% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | 74.25B | 103.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 312.84B |
| Shenzhen Mindray Bio-Medical Electronics | 283.00B |
| WuXi AppTec | 193.34B |
| Aier Eye Hospital Group | 123.47B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.02B |
| Yunnan Baiyao Group Co.,Ltd | 101.35B |
| Shanghai United Imaging Healthcare | 99.90B |
| Sichuan Biokin Pharmaceutical | 93.16B |